Page last updated: 2024-09-05

sb 203580 and ambroxol

sb 203580 has been researched along with ambroxol in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(ambroxol)
Trials
(ambroxol)
Recent Studies (post-2010) (ambroxol)
3,48941,137714130225

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)ambroxol (IC50)
Lysosomal acid glucosylceramidaseHomo sapiens (human)4.1
Cytochrome P450 2D6Homo sapiens (human)0.5574
Sodium-dependent serotonin transporterHomo sapiens (human)3.391

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcaín, FJ; Ariza, J; Barbarroja, N; González-Aragón, D; Jódar, L; López-Pedrera, C; Villalba, JM1

Other Studies

1 other study(ies) available for sb 203580 and ambroxol

ArticleYear
ES936 stimulates DNA synthesis in HeLa cells independently on NAD(P)H:quinone oxidoreductase 1 inhibition, through a mechanism involving p38 MAPK.
    Chemico-biological interactions, 2010, Jul-30, Volume: 186, Issue:2

    Topics: 3T3 Cells; Ambroxol; Animals; Caco-2 Cells; Cell Cycle; DNA; Enzyme Inhibitors; ErbB Receptors; Free Radical Scavengers; HeLa Cells; Humans; Imidazoles; Indolequinones; Kinetics; Mice; NAD(P)H Dehydrogenase (Quinone); p38 Mitogen-Activated Protein Kinases; Pyridines; Pyruvic Acid; Reactive Oxygen Species; RNA, Small Interfering

2010